Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
Cathie Wood's success is based on two main things: finding innovators and betting on them for the long term. The founder and chief executive officer of Ark Invest goes for innovators in all areas, from information technology to healthcare, and this helped her flagship Ark Innovation fund outperform the S 500 Index by a mile last year. Ark Innovation soared 67%, which the benchmark index advanced 24%.
One of Wood's favorite technologies, in the area of healthcare, is gene editing, and last week, she increased her bet by adding to her holdings in two top players: CRISPR Therapeutics (NASDAQ: CRSP) and Intellia Therapeutics (NASDAQ: NTLA). The former recently reached a huge milestone, and the latter is heading for several catalysts over the next two years. Let's check out these top Cathie Wood stocks.
Image source: Getty Images.
Source Fool.com
Intellia Therapeutics Inc Stock
With 12 Buy predictions and not the single Sell prediction the community is currently very high on Intellia Therapeutics Inc.
With a target price of 60 € there is potential for a 209.52% increase which would mean more than doubling the current price of 19.39 € for Intellia Therapeutics Inc.
Comments
